Klaus Hahn
University of North Carolina at Chapel Hill
Klaus Hahn’s lab is focused on the rapid dynamics of signaling studied in living cells. He earned his PhD in organic chemistry from the University of Virginia, followed by postdoctoral work in the Center for Fluorescence Research at Carnegie Mellon University. He began his independent work at Scripps Research Institute, where his laboratory demonstrated new biosensor approaches that revealed precisely timed, localized activations of Rho family GTPases controlling cell polarization and motility. In 2005, Dr. Hahn became Thurman Professor of Pharmacology at the University of North Carolina at Chapel Hill, where he is now focused on systems biology questions, developing high content screening assays to address spatio-temporal regulation of signaling networks, and genetically encoded tools to manipulate protein activity in vivo. He continues to apply these tools to problems of morphodynamics, including metastasis and neurite outgrowth, and to develop reagents and technologies for other researchers. Dr. Hahn works with private funding agencies to support signaling research, is a founding partner of Redstone Biotech, and works with the Sigma and Panomics Companies as a member of scientific and project advisory boards.